Tech Company Financing Transactions
Apse Funding Round
Apse, based in St. Louis, secured $667.1 thousand from private investors.
Transaction Overview
Company Name
Announced On
10/30/2013
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$667,139
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4320 Forest Park Ave. 303
St. Louis, MO 63108
USA
St. Louis, MO 63108
USA
Phone
Website
Email Address
Not Recorded
Overview
Apse is a biotechnology company seeking to commercialize a portfolio of Novel Nanomaterials. We have identified five application areas of immediate, developing, and future needs addressed by technology we invented for which we have several U.S. Patents Pending. This strategy enables a robust financing path for growth.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Killmer
Chief Scientific Officer
Juan Arhancet
Browse more venture capital transactions:
Prev: 10/30/2013: PathoGenetix venture capital transaction
Next: 10/30/2013: Breakthrough Products venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs